Good morning :)
Add to Watchlist
Share
Home
Portfolio
Search
GoldGold
More

ITI Pharma & Healthcare Fund(IDCW)

IDCW
17.810.38% (-0.07)
Investment Checklist

Returns

Fund's average annual rolling returns over the last three years is compared against the funds from the same category

Insufficient Data

Expense Ratio

Expense Ratio is the fee paid by investors of Mutual Funds. Fund's expense ratio is compared against the expense ratio of other funds in the same category to check if the fund is charging more or less compared to other funds in the same category

Less expense ratio implies better returns over the long term

Return vs FD Rates

If fund's return is lower than the average fixed deposit rates offered by banks, investors are better off investing the amount in a FD

Insufficient Data

Red Flags

We check for various red flags on fund's portfolio holdings like - ratings for debt securities, pledging of promoter shares in the company, default probabiity of the company, stocks presense in negative lists published by the exchanges etc. Checkout the Holdings section in the Portfolio tab for full list of securties with red flags

Total holdings with red flags is insignificant

ITI Pharma & Healthcare Fund(IDCW)

IDCW
EquitySectoral Fund - Pharma & Health Care
Small-size FundAssets Under Mgmt: ₹ 194 Cr
Very High RiskPrinciple investment will be at very high risk
17.810.38% (-0.07)

Price Chart

High
—
Low
—
Returns
0.00%
1M
6M
1Y
3Y
5Y
Max
SIP
Loading...
1M
6M
1Y
3Y
5Y
Max
SIP
Investment Checklist

Returns

Fund's average annual rolling returns over the last three years is compared against the funds from the same category

Insufficient Data

Expense Ratio

Expense Ratio is the fee paid by investors of Mutual Funds. Fund's expense ratio is compared against the expense ratio of other funds in the same category to check if the fund is charging more or less compared to other funds in the same category

Less expense ratio implies better returns over the long term

Return vs FD Rates

If fund's return is lower than the average fixed deposit rates offered by banks, investors are better off investing the amount in a FD

Insufficient Data

Red Flags

We check for various red flags on fund's portfolio holdings like - ratings for debt securities, pledging of promoter shares in the company, default probabiity of the company, stocks presense in negative lists published by the exchanges etc. Checkout the Holdings section in the Portfolio tab for full list of securties with red flags

Total holdings with red flags is insignificant

EquitySectoral Fund - Pharma & Health Care
Small-size FundAssets Under Mgmt: ₹ 194 Cr
Very High RiskPrinciple investment will be at very high risk

Key Metrics

Expense RatioExpense RatioNo LabelNo LabelNo LabelNo Label
0.4758.823.45
No LabelNo LabelNo LabelNo LabelNo LabelNo Label
1.5052.303.35

Scheme Info

PlanPlanLock inLock inExit LoadExit Load
IDCW0 yrs1.00%
1% on or before 12M Nil after 12M
SIP Inv.SIP Inv.Min. LumpsumMin. Lumpsum
Allowed₹ 5,000
Initial: ₹ 5,000 Incremental: ₹ 1,000
BenchmarkBenchmark
Nifty Healthcare Index - TRI

About Sectoral Fund - Pharma & Health Care

Sectoral Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.

Peers & Comparison

Comparing 3 mutual funds from 
EquitySectoral Fund - Pharma & Health Care

Returns

Scheme

Ratios

Loading...
Mutual Fund1Y Returns1Y Returns3Y CAGR3Y CAGRLife CAGRLife CAGR
ITI Pharma & Healthcare Fund(IDCW)56.33%—21.96%
Nippon India Pharma Fund(IDCW)41.04%15.13%12.22%
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(IDCW-Payout)50.48%12.77%17.22%
SBI Healthcare Opp Fund(IDCW-Payout)51.64%21.85%17.41%

Price Comparison

Compare ITI Pharma & Healthcare Fund(IDCW) with any MF, ETF, stock or index
Compare ITI Pharma & Healthcare Fund(IDCW) with any MF, ETF, stock or index
ITI Pharma & Healthcare Fund(IDCW)
Hmm, looks like data is unavailable here. Please come back after some time
Loading...

Asset Allocation

Actual

Target

Dec 2023

Mar 2024

Jun 2024

Aug 2024

ACTUAL
Cash & EquivalentsEquity1.11%98.89%

Dec 2023

Mar 2024

Jun 2024

Aug 2024

Tickertape Separator

Sector Distribution

Fertilizers & Agro ChemicalsDiversified ChemicalsOthersLabs & Life Sciences ServicesPharmaceuticals0.98 %1.83 %3.80 %13.34 %80.05 %

Dec 2023

Mar 2024

Jun 2024

Aug 2024

Tickertape Separator

Sector Weightage

Jun 23Sep 23Dec 23Mar 24Jun 24Aug 2468.01%75.36%74.18%74.51%75.94%80.05%
Pharmaceuticals as a % of total holdings for last six quarters
Tickertape Separator

Current Holdings

Equity

Others

  • Constituent
    Holding Weight
    3M Change
  • Sun Pharmaceutical Industries Ltd
    SUNPHARMA
    3M change : 0.35 %

    Holdings

    15.92 %

    0.35 %
  • Lupin Ltd
    LUPIN
    3M change : 1.07 %

    Holdings

    7.04 %

    1.07 %
  • Apollo Hospitals Enterprise Ltd
    APOLLOHOSP
    3M change : -0.25 %

    Holdings

    5.55 %

    -0.25 %

AMC Profile

ITI Asset Management Holding Ltd. operates as a buy-side intermediation, advisory and asset management business in Emerging and Global Markets. It provides clients access to alternative investments, ETFs and other products of a different risk levels and investment horizons.

  • No.of Schemes

    18

  • Total AUM

    ₹ 9,055.44 Cr.

Fund Manager Profile

Rohan Korde

AUM:  ₹7,725.20 Cr.

Sum of AUMs of all funds managed by the fund manager

 | 

Exp: —

Dhimant Shah

AUM:  ₹7,497.16 Cr.

Sum of AUMs of all funds managed by the fund manager

 | 

Exp: 18yrs

Manager Performance (0)

Loading...

Tax Implications

Invested period < 1 year

Gains are treated as short-term capital gains and taxed at 20%

Invested period > 1 year

Gains are treated as long-term capital gains and taxed at 12.5%

Let’s calculate your returns after tax

Investment frequency

Monthly

One Time

Monthly Investment Amt. (₹)

Investment period (years)

CAGR (%)
This CAGR is calculated based on the actual past return given by the fund during the selected investment period. This is the annualised growth rate assuming monthly compounding.

+

-

You make

Opinions and Fund Reviews

The content here in the form of articles and videos is for information purposes only and may have been sourced from publicly available sources or otherwise. Tickertape does not guarantee the authenticity and veracity of the material shared. The User understands and agrees that Tickertape is not aware nor liable for any content shared here.
Hmm, looks like data is unavailable here. Please come back after some time.